Theravance Biopharma, Inc.·4

Mar 3, 8:38 PM ET

Sawaf Aziz 4

4 · Theravance Biopharma, Inc. · Filed Mar 3, 2023

Insider Transaction Report

Form 4
Period: 2023-03-01
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Ordinary Shares

    2023-03-01+80,000277,717 total

Documents

1 file
  • 4
    form4-03042023_010338.xmlPrimary